Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

Aurobindo Pharma Ltd share price: Shares of Aurobindo Pharma gained 2.9 per cent in trade, registering an intraday high at ₹1,222.9 on the BSE. The up move in the stock came after the company arm ...

Aurobindo Pharma gained nearly 3% in trade on Wednesday, April 23, after it said its wholly-owned subsidiary, Eugia Pharma Specialities Limited, received the final approval from the US Food & Drug ...

Aurobindo Pharma made an announcement stating that its fully-owned subsidiary, Eugia Pharma Specialities Limited, has got final USFDA approval to make and sell Dasatinib Tablets in the US.

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Eugia PharmaSpecialities Limited, has received final approval from the US Food & Drug Administration (USFDA) to ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Aurobindo Pharma's subsidiary, Eugia Pharma Specialities Ltd, received USFDA approval for its generic Dasatinib tablets, used in treating certain bone marrow and blood cancers. The approval covers ...

Aurobindo Pharma Ltd on Wednesday said its wholly- owned arm Eugia Pharma Specialities Ltd has received final approval from the USFDA to manufacture and market its generic version of Dasatinib tablets ...

Aurobindo Pharma rose 1.81% to Rs 1,209.60 after its wholly owned subsidiary, Eugia Pharma Specialities, received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and ...

Return on investment - most recent fiscal year 10.35 ...

View a comprehensive summary of the Aurobindo Pharma share, providing essential insights into its performance. Signals range from Strong Buy, Buy, Neutral, Sell, to Strong Sell, helping gauge the ...